Table 2 Clinical outcomes according to reactivation status
|  | Reactivation (n = 67) | Non-reactivation (n = 56) | p value |
|---|---|---|---|
Duration of mechanical ventilationa (days) | 34 (22–52.5) | 17.5 (9–28) | < 0.01 |
Ventilator-free days at D28a (days) | 0 (0–0) | 0 (0–0) | 0.16 |
Weaned from ECMO (%) | 40 (60) | 27 (48) | 0.28 |
Duration of ECMOa (days) | 15 (10–22.5) | 9 (5–14) | < 0.01 |
ECMO-free days at D28a (days) | 0 (0–16) | 0 (0–17) | 0.75 |
ICU mortality (%) | 34 (51) | 33 (59) | 0.47 |
Hospital mortality (%) | 35 (52) | 33 (59) | 0.58 |
ICU length of staya (days) | 29 (19.5–47.5) | 16 (9–30) | < 0.01 |
Hospital length of staya (days) | 44 (29–63.5) | 24 (11–43) | < 0.01 |
Pulmonary fibrosis (%) | 16 (24) | 8 (14) | 0.27 |
Transfusion of blood productsa | 11 (7–21.5) | 10 (6–15) | 0.05 |